BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PRKCA
,
calcium channel activity
,
Allergy to pollen
,
Retina
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bifeprunox
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Bifeprunox versus placebo for schizophrenia.
Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water i…
Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulat…
Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking…
Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucl…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bifeprunox Extension to Extension Study in Patients With Schizophrenia
Efficacy of Bifeprunox in Patients With Schizophrenia
Efficacy of Bifeprunox in Patients With Schizophrenia
Bifeprunox in the Treatment of Schizophrenia
Bifeprunox in the Treatment of Schizophrenia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ